Categories: Pharma & Healthcare
Format :
Market Overview
The global Implantable Cardiac Monitors Market anticipated to grow at a CAGR of 7.5% to reach US$ 1250.25 Million by the end of 2030.
Market Report Service Insights can provide in-depth research reports highlighting Market and competitive information in key Market segments. The report also considers the impact of COVID-19 on the global Implantable Cardiac Monitors Market. This report considers the historical period 2018-2022, the base year 2022, and the forecast period 2023-2030. This report provides a quantitative analysis of the Market supported by Market drivers, challenges, and trends to accurately describe the Market scenario and competition.
Key Development
On Jan 21, 2021, Boston Scientific Corporation announced its plans to acquire a privately-held company- Preventice Solutions Inc., which currently has a full portfolio of mobile cardiac health solutions and services with a wide range of products such as short and long-term Holter monitors, mobile cardiac telemetry and ambulatory cardiac monitors in the Implantable Cardiac Monitors market. Boston Scientific has been associated with Preventice Solutions since 2015 as an investor.
On September 23, 2020, Medtronic announced first enrollments in the ALLEVIATE-HF clinical trial that is aimed at evaluating the ability of its Reveal LINQ™ Insertable Cardiac Monitor (ICM) in identifying patients at high risk of worsening heart failure. The aim of the trial is focused on determining if early information provided by the LINQ devices enables clinicians to take action before patients’ conditions worsen. The LINQ device will alert clinicians if a patient is at high risk for a heart failure event, allowing time for a physician to adjust medications to enhance patient health. The trial started on September 3, 2020, and is expected to be completed in June 2022.
Report Scope
Report Data | Implantable Cardiac Monitors Market |
Implantable Cardiac Monitors Market Forecast | 1250.25 Million (2023-2030) |
Implantable Cardiac Monitors Market CAGR 2023 - 2030 | 7.5% |
Implantable Cardiac Monitors Market Analysis Period | 2023 - 2030 |
Implantable Cardiac Monitors Market Base Year | 2022 |
Implantable Cardiac Monitors Market Forecast Data | 2023 - 2030 |
Segments Covered | By Type, By Application, And by Regions |
Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled | Abbott Laboratories, Phoenix Heart PLLC, Biotronik, Edwards Life Science, GE Healthcare, Boston Scientific Co, Medtronic Plc, Koninklijke Philips (Philips Healthcare), Nihon Kohden Co, Livanova Plc (Sorin) |
Key Segments | Key Segment by Type Cardiac Arrhythmias Atrial Fibrillation Epilepsy & Unexplained Falls Key Segment by Application Hospitals Cardiac Center & Clinics Ambulatory Surgical Centers (ASCs) |
Report Coverage | Market Drivers, Market Trends, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
FAQ
The global Implantable Cardiac Monitors Market anticipated to grow at a CAGR of 7.5% to reach US$ 1250.25 Million by the end of 2030.
North America is expected to hold the largest share of the global Implantable Cardiac Monitors Market.
The key Implantable Cardiac Monitors Market players profiled in the report include Abbott Laboratories, Phoenix Heart PLLC, Biotronik, Edwards Life Science, GE Healthcare, Boston Scientific Co, Medtronic Plc, Koninklijke Philips (Philips Healthcare), Nihon Kohden Co, Livanova Plc (Sorin) and others.
Global Implantable Cardiac Monitors Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
Corporate strategies have a separate section:
Companies are focusing on cross-border development, product differentiation and other methods to maintain Market share. Established companies in particular need to understand the overall Market composition and the capabilities of regional players in order to implement these approaches.
The study provides company profiles with detailed reports on key metrics. These developments give readers the knowledge they need to make smart decisions while also helping them focus on attracting customers and growing their businesses.
Due to the unexpected COVID-19 epidemic, there is a temporary shift in the demand of the global Implantable Cardiac Monitors Market.
As a result, Market sizes that accurately represent the impact of COVID-19 can be assessed and predicted using real-time trends.
Key reasons to buy this report:
Base Year:2022
Historical Data:2022-2030
No of Pages:173
Single User
Multi User
Corporate User
Only one user can access the report. It cannot be printed or shared. Delivery in online PDF.
US $ 3450
Multiple users can access the report. It cannot be printed or shared. Delivery in online PDF.
US $ 5250
The entire organization can use the report. It can be printed and shared. Delivery in PDF and Excel. Free update of the report after 1 year.
US $ 7000
Email: [email protected]